Top cancer specialists are urging men to look past the common symptoms of aging and recognize these critical warning signs. It’s often said that if you have your health, you have everything, and there ...

NORMAL, Ill. (WLS) -- Two Illinois State University students were among six people injured in an off-campus shooting in Normal early Sunday morning, police said. Normal police said officers responded ...

The lifetime risk of dementia for Americans aged 55 and older is now estimated at 42%. Early signs of dementia are often noticed by others first and can include poor judgment or repeating oneself.

This review is based on a screening at the South by Southwest Film & TV Festival. Normal will be released in theaters on April 17. The film is set in the fictitious, snow-draped Normal, Minnesota ...

NORMAL, Ill. (WMBD) – Six people, including two college students, were hospitalized after an early Sunday morning shooting in Normal, Illinois. Normal Police were called to the 700 block of Franklin ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The Transform trial, a collaborative effort funded by Prostate Cancer UK and the ...

Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research. The findings are ...

The lifetime risk of dementia for Americans aged 55 and older is now estimated at 42%. Early signs of dementia are often noticed by others first and can include poor judgment or repeating oneself.

Pfizer is eyeing an earlier use of its PARP inhibitor Talzenna after a positive phase 3 trial in metastatic hormone-sensitive prostate cancer (mHSPC). The phase 3 Talapro-3 trial met its primary ...

Transdermal estradiol (tE2) is an alternative to luteinizing hormone–releasing hormone (LHRH) agonists as androgen-deprivation therapy in patients with prostate cancer. With tE2, testosterone is ...